Medical Data Vision Co., Ltd.
Notice Regarding Recording of Extraordinary Loss (Impairment Loss on Investment Securities)
Recorded an extraordinary loss of 290 million yen due to a decline in the market value of investment securities in the Q4 consolidated accounting period of the fiscal year ending December 2025, reflected in the financial summary.
Key Figures
- Extraordinary Loss (Impairment Loss on Investment Securities): 290 million yen
- Applicable Period: Q4 consolidated accounting period for the fiscal year ending December 2025
- Financial Summary Reflection Date: 2026-02-09
AI要約
Regarding Recording of Extraordinary Loss
Medical Data Vision Co., Ltd. recorded an impairment loss of 290 million yen as an extraordinary loss for the Q4 consolidated accounting period of the fiscal year ending December 2025 due to a significant decline in the market value or intrinsic value of certain investment securities held, compared to their acquisition cost.
Impact on Financial Results
This extraordinary loss is reflected in the "Financial Summary for the Fiscal Year Ending December 2025 [Japanese GAAP] (Consolidated)" announced on the same day, and impacts the financial results; however, the specific impact amount and effect on net income are unknown.
